Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What You'll Want to Know About ImmunoGen's Q2 Results


There wasn't much to be thrilled about the last time ImmunoGen (NASDAQ: IMGN) announced its quarterly results in May. Revenue decreased. The biotech's net loss worsened.

But that's old news. ImmunoGen announced its second-quarter results after the market opened on Friday. It was a much different story this time around. Here are the highlights from the company's Q2 update.

Image source: Getty Images

Continue reading


Quelle Fool.com

Like: 0
Share

Comments